HISUN(SH:600267) Zheng Quan Ri Bao·2026-02-05 14:16Core Viewpoint - Haizheng Pharmaceutical announced the approval of the third unlock condition for its 2021 restricted stock incentive plan, allowing 572,250 shares to be released from restrictions, benefiting 66 individuals [2]. Group 1 - The company held its 13th meeting of the 10th Board of Directors on February 5, 2026, to review the proposal regarding the unlock conditions of the restricted stock incentive plan [2]. - The proposal was approved by the Board's Compensation and Assessment Committee and is in accordance with the authorization from the company's second extraordinary general meeting in 2021 [2]. - After completing the procedures for the release of the restricted stock, the company will issue an announcement regarding the release and listing of the stock [2].